About Aptar Pharma India Private Limited
Data last updated:
Aptar Pharma India Private Limited is a private limited company based in Kalyan, Maharashtra, India, a subsidiary of Aptar Group Inc. It operates in the bottle and cap manufacturing segment of the packaging sector. It was incorporated on 05 July 1999 and has been in existence for over 27 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U29195MH1999PTC207807. Its GSTIN is 27AAACV8607M1ZV (Maharashtra). The company holds 5 GST registrations, of which 4 are active.
The company has an authorised share capital of ₹7.8 Cr and a paid-up capital of ₹74.37 Lakh. It was formerly known as Valois India Private Limited. It is led by directors including Sanjay Digambar Kapote and Anand Nanjayya Hiremath.
Its last annual general meeting (AGM) was held on 15 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B Lodha Industrial And Logistics Park, Kalyan, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹502.38 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹86.85 Cr (net margin 17.3%) and EBITDA of ₹144.87 Cr (EBITDA margin 28.8%). Revenue has grown at a compounded annual rate (CAGR) of 17% over three years and 18% over five years.
The company has about 320 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aptar. Court records list 6 cases involving the company, including 3 filed by the company and 3 filed against it; 2 cases are pending. The company has 2 deals on record (2 rights issues); the latest was in April 2023. The company has 8 MSME Form 1 returns on record between 2021 and 2024, listing 231 overdue payments to 90 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aptar.com.
Company details
CIN history
Aptar Pharma India has one previous CIN (Corporate Identification Number): U29195DL1999PTC100534. The current CIN is U29195MH1999PTC207807, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U29195MH1999PTC207807 | Current |
| U29195DL1999PTC100534 | Previous |
Contact details
Aptar Pharma India Private Limited's registered office is in Kalyan, Maharashtra. Its website is aptar.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered AddressA1 Survey No. 120/3/A And B 120/4 120/7 120/10/B Lodha Industrial And Logistics Park, Usatane Ambarnath Thane, Kalyan, Maharashtra, India – 421306
- IndustryPackaging, Bottle & Cap Manufacturing
To see the full contact details of Aptar Pharma India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Aptar Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aptar Pharma India Private Limited, buy the company report.
Financials of Aptar Pharma India Private Limited
FY 2025 filings availableAptar Pharma India Private Limited reported revenue of ₹502.38 Cr (up 14% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 14% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹144.87 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹86.85 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 28.8% | ||||
| Net Profit Margin | 17.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aptar Pharma India Private Limited, buy the company report.
Board of directors of Aptar Pharma India Private Limited
Aptar Pharma India has 3 current directors and 13 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sanjay Digambar Kapote | Director | 13 Mar 2023 | 3 Years 7 Months | Current |
| Anand Nanjayya Hiremath | Director | 28 Jun 2022 | 4 Years 3 Months | Current |
| Gael Philippe Dominique Touya | Director | 11 Feb 2019 | 7 Years 8 Months | Current |
Auditor
Aptar Pharma India Private Limited is audited by Price Waterhouse Chartered Accountants LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Price Waterhouse Chartered Accountants LLP | FY 2023 | 012754N/N500016 |
Shareholding
The shareholding of Aptar Pharma India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aptar Pharma India Private Limited, buy the company report.
Deals & funding
Aptar Pharma India Private Limited has 2 deals on record (2 rights issues); the latest was in April 2023.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Apr 2023 | Rights issue | ₹16.5 Cr | Investors: Aptar Group Inc |
| Aug 2021 | Rights issue | ₹44.4 Cr | Investors: Aptar Group Inc |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Aptar Pharma India Private Limited has 6 court cases on record: 3 filed by Aptar Pharma India, 3 filed against it. 2 cases are pending and 4 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 4 | 1 | 1 |
| Supreme Court | 2 | 2 | 1 |
Cases on record (5 of 6)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Mumbai City Civil Court, Maharashtra | Commercial suit | Filed by the company against Narang Access Private Limited | Pending |
| District court, Mumbai City Civil Court, Maharashtra | Interim or miscellaneous application | Filed by the company against Narang Access Private Limited | Disposed |
| Supreme Court | Court case | Filed against the company by PR. Commissioner of Customs | Pending |
| Supreme Court | Arbitration matter | Filed against the company by an individual | Disposed |
| District court, Mumbai Small Causes Court, Maharashtra | Court case (LE) | Filed against the company by an individual | Disposed |
To see the full case history of Aptar Pharma India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Aptar Pharma India Private Limited has 8 MSME Form 1 returns on record between 2021 and 2024, listing 231 overdue payments to 90 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 90)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Vijay Anand Packaging Industries LLP | |||
| Premium Polymers Limited | |||
| Parth Enterprises | |||
| Aaradhana Plastics Private Limited | |||
| Innov Controls Technology India Private Limited |
To see the full MSME payment records of Aptar Pharma India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Aptar Pharma India Private Limited has a workforce of 320 employees on its EPFO records as of Apr 08, 2024, across 3 active EPFO establishments.
GST
Aptar Pharma India has 5 GST registrations: 4 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAACV8607M1ZV | Maharashtra | Active | 01 Jul 2017 |
| 27AAACV8607M2ZU | Maharashtra | Active | 10 Mar 2025 |
| 36AAACV8607M1ZW | Telangana | Active | 02 Jan 2019 |
| 02AAACV8607M1Z7 | Himachal Pradesh | Active | 08 Jan 2019 |
To see the full GST registrations and return filing status of Aptar Pharma India Private Limited, buy the company report.
Recent activity
Aptar Pharma India Private Limited has 16 board changes on record since 2005: 3 appointments and 13 cessations. The latest: Sanjay Digambar Kapote ceased to be Additional Director on 10 Nov 2023.
7 earlier events are in the company report.
News
Frequently asked questions
Aptar Pharma India is an active private limited company based in Kalyan, Maharashtra, India. The company works in bottle and cap manufacturing, within the packaging industry. It was incorporated on 05 July 1999 (27+ years old) and is registered under CIN U29195MH1999PTC207807.
Aptar Pharma India has 3 current directors:
- Sanjay Digambar Kapote - Director
- Anand Nanjayya Hiremath - Director
- Gael Philippe Dominique Touya - Director
The latest financial statements of Aptar Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 15 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aptar Pharma India is 27AAACV8607M1ZV, registered in Maharashtra. The company has 5 GST registrations in all, of which 4 are active and 1 is cancelled or inactive. Other active GSTINs include 27AAACV8607M2ZU (Maharashtra), 36AAACV8607M1ZW (Telangana), 02AAACV8607M1Z7 (Himachal Pradesh).
The CIN (Corporate Identification Number) of Aptar Pharma India is U29195MH1999PTC207807. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aptar Pharma India has 6 court cases on record: 3 filed by the company and 3 filed against it. 2 are pending. Most are in the district courts.
Aptar Pharma India was incorporated on 05 July 1999, making it 27+ years old. It is registered with the Registrar of Companies, Mumbai.
Aptar Pharma India has 2 deals on record (2 rights issues); the latest was in April 2023.
Sanjay Digambar Kapote ceased to be Additional Director on 10 Nov 2023. Jean Marc Pardonge ceased to be Director on 13 Mar 2023. Sanjay Digambar Kapote was appointed as Director on 13 Mar 2023. Aptar Pharma India has 16 board changes on record in total.
Aptar Pharma India has 8 MSME Form 1 returns on record between 2021 and 2024, listing 231 overdue payments to 90 micro and small suppliers. The latest return was filed on 29 Apr 2024.
Aptar Pharma India can be reached through the website aptar.com. Its registered office is in Kalyan, Maharashtra, India.